MedTrace Logo

Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia

NCT04320225 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-09-09

No results posted yet for this study

Summary

The project was undertaking by Qilu Hospital of Shandong University in China. The objective is to find out if there is a connection between vitamin D level and the efficacy of dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).

Conditions

Interventions

DRUG

Dexamethasone

HD-DXM (orally at 40 mg daily for 4d )

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-03-01
Completion
2021-10-01
FDA Drug
Yes

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04320225 on ClinicalTrials.gov